CTM stock forecast, quote, news & analysis
Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets... Show more
Castellum, Inc. (CTM) Stock Analysis: Navy Contract Fuels Momentum
Key Takeaways
- Castellum secured a $49.8 million Navy recompete contract for its SSI subsidiary, bolstering revenue visibility.
- Stock spiked on the contract news but has trended lower amid broader market pressures and insider sales.
- Maxim Group maintained a Buy rating, highlighting growth potential with a $3 target.
- Q3 revenue rose to $14.6 million with first positive net income, signaling operational improvements.
- Trading near 52-week lows around $0.86, with market cap under $82 million and analyst upside to $3.50.
Current Market Snapshot
Castellum, Inc. (CTM) has navigated volatile trading in recent weeks, reflecting its position as a micro-cap defense tech provider. The stock experienced a sharp intraday surge tied to major contract news before settling into a gradual downtrend amid elevated volumes. Operating in cybersecurity and electronic warfare for federal clients, CTM maintains a modest market cap below $100 million, with shares lingering near the lower end of the 52-week range. Fundamentals show revenue stability around $50 million TTM, but profitability remains a work in progress despite recent quarterly gains. Investor focus centers on contract backlogs and execution amid sector tailwinds in national security spending.
Recent Developments Driving CTM Price Action
Castellum, Inc. (CTM), a Vienna, Virginia-based provider of cybersecurity, electronic warfare, software engineering, and intelligence services primarily to U.S. federal government clients, has seen its stock price influenced by a series of contract wins, executive updates, and insider activity over the past 30 days. The most significant catalyst emerged on January 7, 2026, when the company announced a $49.8 million recompete contract awarded to its Specialty Systems, Inc. (SSI) subsidiary by the U.S. Navy. This multi-year deal extends existing work in mission-critical support services, adding substantial backlog and reinforcing CTM's foothold in naval programs. Shares surged that day, closing up from prior levels with volume exceeding 6.4 million—far above average—peaking intraday near $1.11 before moderating.
On January 13, 2026, Maxim Group reiterated its Buy rating on CTM, citing the Navy win as evidence of sustained growth momentum and positioning for further federal opportunities. Analysts pointed to the company's expanding pipeline in cybersecurity and electronic warfare, with a $3 price target implying significant upside from sub-$1 levels. This followed positive commentary on January 8 framing the contract as a key extension of CTM's capabilities.
Earlier in the period, on January 2, 2026, Castellum disclosed updates to senior executive compensation, setting base salaries at $290,000 for its General Counsel and COO, alongside revised termination notice provisions. This move aimed to align leadership incentives with long-term performance amid ongoing contract pursuits. However, investor sentiment faced headwinds from late December insider sales reported into early January, including transactions by top executives, which coincided with a post-spike pullback. Shares dipped from $1.06 highs post-contract to around $0.90 by late January, reflecting profit-taking and micro-cap volatility.
Prior Q3 results from November 2025 provided a solid backdrop, with revenue climbing 26% year-over-year to $14.6 million and net income flipping positive at $415,000—the company's first quarterly profit. TTM revenue stands at $50.6 million, supporting optimism despite ongoing losses on an annual basis (EPS -0.06). No new earnings were reported in the period, with Q4 guidance pending into late February. Macro factors, including steady U.S. defense budgets and rising cyber threats, underpin demand, though broader small-cap weakness pressured CTM lower after the initial rally. Overall, contract momentum drove upside bursts, tempered by insider activity and market dynamics, resulting in net price erosion from January peaks.
2026 Outlook and Key Factors to Monitor
As Castellum advances through 2026, investors should track its ability to convert recent contract wins like the $49.8 million Navy recompete into steady revenue execution. With a focus on federal cybersecurity, electronic warfare, and software services, the company benefits from elevated national security priorities and potential budget increases under ongoing geopolitical tensions. Backlog growth from subsidiaries such as SSI and joint ventures will be critical, alongside Q4 earnings expected late February, which could highlight profitability progress following Q3's positive shift.
Risks include execution delays on multi-year deals, competition in IDIQ vehicles like OASIS+ and Missile Defense Agency awards from December, and debt management post prior paydowns. Opportunities lie in strategic acquisitions to bolster AI-driven cyber tools and program management, potentially expanding commercial exposure beyond government clients. Regulatory shifts in federal procurement and macroeconomic pressures on small-cap valuations warrant attention. Competitive positioning against larger peers in IT services and sustained analyst support, including Buy ratings with $3+ targets, could catalyze rerating if revenue scales toward $60 million as implied by pipeline strength. Balanced monitoring of quarterly results, win rates, and insider alignment will shape the year's trajectory.
CTM in upward trend: 10-day moving average broke above 50-day moving average on May 27, 2026
The 10-day moving average for CTM crossed bullishly above the 50-day moving average on May 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where CTM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 17, 2026. You may want to consider a long position or call options on CTM as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CTM just turned positive on June 18, 2026. Looking at past instances where CTM's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
CTM moved above its 50-day moving average on June 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CTM advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 133 cases where CTM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for CTM moved out of overbought territory on June 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CTM broke above its upper Bollinger Band on May 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.971) is normal, around the industry mean (7.266). P/E Ratio (0.000) is within average values for comparable stocks, (67.823). CTM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.983). CTM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (1.307) is also within normal values, averaging (20.714).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InformationTechnologyServices